SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

SPRB

Spruce Biosciences Inc.
NASDAQHealth Care

Latest close: 41.45 USD · Jul 29, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 12, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 12, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Jul 27, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year194
SEC filings on record34023 flagged findings
Reported transactions (Form 4)80since Dec 16, 2024 · and 2 other holdings
Corporate events (8-K)30since Dec 2, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-13listing compliance noticerecentOpen filing ↗
    “…through Jefferies acting as the sales agent and/or principal. As of March 31, 2026, the Company has no t issued any shares of…”
    +1 more passage from the same document
    • “…affect the market liquidity of our common stock and the market price of our common stock could decrease. On April 26, 2024, we…”
  • 2026-05-13capital return (buybacks/dividends)recentOpen filing ↗
    “…in Ukraine and the Middle East and related sanctions. If we raise additional funds by issuing equity securities, our stockholders…”
  • 2026-05-13Department of Justice inquiryrecentOpen filing ↗
    “…and other jurisdictions are also increasingly scrutinizing certain data transfers (including to the extent related to personal,…”
    +1 more passage from the same document
    • “…our other current and future product candidates and generate revenue and could require us to expend significant time and resources…”
  • 2026-05-13reverse splitrecentOpen filing ↗
    “…pursuant to which it may elect to issue and sell, from time to time, shares of common stock having an aggregate offering…”
    +1 more passage from the same document
    • “…comply with the minimum bid price requirement under the Nasdaq Capital Market . As a result, the Company’s common stock began trading…”
  • 2026-04-22share offering or dilution eventrecentOpen filing ↗
    “…21, 2026. The gross proceeds from the Offering will be approximately $69.0 million before deducting underwriting discounts and…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:75 on Aug 5, 2025) · 1:75 cumulative

The other times: of 768 securities that did their first reverse split in 5 years, a year later the median was worth 0.55× the price on the day of the split; 353 lost more than half and 201 rose (768 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 340)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Aug 14, 26SCHEDULE 13G ↗Passive stake · AWM Investment Company, Inc. · 5.1% · event on Jun 30, 26
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · ADAR1 Capital Management, LLC · 2.5% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Kenneth Griffin · 1.9% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · OrbiMed Advisors LLC · 4.8% · event on Jun 30, 26
  • Aug 12, 2610-Q ↗Quarterly report
  • Aug 12, 268-K ↗Current report · Results
  • Aug 4, 26SCHEDULE 13G/A ↗Passive stake · Integrated Core Strategies (US) LLC · 5.8% · event on Jun 30, 26 · amendment
  • Jul 30, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 6.8% · event on Jun 30, 26
  • Jul 29, 26Form 4 ↗Insider transaction
  • Jul 29, 26Form 3 ↗Insider transaction
  • Jul 27, 26SCHEDULE 13G ↗Passive stake · Orin Hirschman · 9.1% · event on Jun 30, 26
  • Jul 27, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • May 26, 268-K ↗Current report · Shareholder vote results
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Squadron Master Fund LP · 0.9% · event on Mar 31, 26 · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Alyeska Investment Group, L.P. · 4.5% · event on Mar 31, 26 · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Citadel Advisors LLC · 5.1% · event on Mar 31, 26 · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Wellington Management Group LLP · 3.6% · event on Mar 31, 26 · amendment
  • May 13, 2610-Q ↗Quarterly report
  • May 13, 268-K ↗Current report · Results

340 filings on record, the oldest from Sep 4, 20.

Listing the 25 most recent filings of the 340 on record.

8-Ks, explained

Stress6Structure17Governance11
  • Jul 27, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 22, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Mar 20, 26StructureA material agreement was terminated8-K 1.02 ↗
  • Mar 9, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jan 8, 26StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2025show all 3hide
    • Dec 15, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 12, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Oct 17, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 8, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jun 12, 25StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • May 29, 25StructureEntered a material agreement+6 more in the same filing8-K 1.01 ↗
  • Apr 25, 25StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Dec 27, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Oct 28, 24StressListing notice (8-K 3.01)8-K 3.01 ↗

7 older filings not shown · The record reaches back to Feb 25, 21.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Apr 30, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Mar 13, 24StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗

The full record holds 6 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • The Carlyle Group Inc.4.7%Feb 18, 26SCHEDULE 13D/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum.
  • John P. McKearn, Ph.D.4.2%Jan 7, 25SCHEDULE 13D/A ↗12 co-filers on this document — the figure is the largest single stake, not their sum.
  • HealthCap VIII, L.P.3.4%Oct 7, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Orin Hirschman9.1%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.6.8%Jun 30, 26SCHEDULE 13G ↗
  • Integrated Core Strategies (US) LLC5.8%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • AWM Investment Company, Inc.5.1%Jun 30, 26SCHEDULE 13G ↗
  • Citadel Advisors LLC5.1%Mar 31, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
show 8 more holdershide
  • OrbiMed Advisors LLC4.8%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Ikarian Capital, LLC4.8%Apr 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Alyeska Investment Group, L.P.4.5%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Wellington Management Group LLP3.6%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • ADAR1 Capital Management, LLC2.5%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Kenneth Griffin1.9%Jun 30, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
  • Squadron Master Fund LP0.9%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • ExodusPoint Capital Management, LP0.8%Apr 22, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 6, 25Buy$5KParkman Healthcare Partners LLC↗
  • Oct 6, 25Sell$4KParkman Healthcare Partners LLC↗
  • Oct 6, 25Sell$436Parkman Healthcare Partners LLC↗
  • Oct 6, 25Buy$5KParkman Healthcare Partners LLC↗
  • Oct 6, 25Sell$4KParkman Healthcare Partners LLC↗
  • Oct 6, 25Sell$436Parkman Healthcare Partners LLC↗
Stock compensation, tax and giftsshow the 34 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 30, 26Compensation$1KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 31, 25Compensation$21KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 15, 25Compensationamount n/aSamir M. GharibPRESIDENT AND CFO↗
  • Dec 15, 25Tax$14KSamir M. GharibPRESIDENT AND CFO↗
  • Dec 15, 25Compensationamount n/aSamir M. GharibPRESIDENT AND CFO↗
  • Dec 15, 25Tax$15KSamir M. GharibPRESIDENT AND CFO↗
  • Dec 15, 25Compensationamount n/aJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 15, 25Tax$61KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 15, 25Compensationamount n/aJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 15, 25Tax$49KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 11, 25Compensationamount n/aSamir M. GharibPRESIDENT AND CFO↗
  • Dec 11, 25Tax$60KSamir M. GharibPRESIDENT AND CFO↗
  • Dec 11, 25Compensationamount n/aJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 11, 25Tax$194KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 11, 25Compensationamount n/aDouglas Kirk WaysInterim Chief Medical Officer↗
  • Dec 10, 25Compensationamount n/aSamir M. GharibPRESIDENT AND CFO↗
  • Dec 10, 25Tax$16KSamir M. GharibPRESIDENT AND CFO↗
  • Dec 10, 25Compensationamount n/aJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 10, 25Tax$37KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Oct 20, 25Compensationamount n/aSamir M. GharibPRESIDENT AND CFO↗
  • Oct 20, 25Tax$98KSamir M. GharibPRESIDENT AND CFO↗
  • Oct 20, 25Compensationamount n/aJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Oct 20, 25Tax$228KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 16, 24Compensationamount n/aJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 16, 24Tax$12KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 16, 24Compensationamount n/aJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 16, 24Tax$15KJavier B. SzwarcbergCHIEF EXECUTIVE OFFICER↗
  • Dec 16, 24Compensationamount n/aSamir M. GharibPRESIDENT AND CFO↗
  • Dec 16, 24Tax$5KSamir M. GharibPRESIDENT AND CFO↗
  • Dec 16, 24Compensationamount n/aSamir M. GharibPRESIDENT AND CFO↗
  • Dec 16, 24Tax$5KSamir M. GharibPRESIDENT AND CFO↗
  • Dec 16, 24Compensationamount n/aRalph William Charlton IIICHIEF MEDICAL OFFICER↗
  • Dec 16, 24Tax$4KRalph William Charlton IIICHIEF MEDICAL OFFICER↗
  • Dec 16, 24Compensationamount n/aRalph William Charlton IIICHIEF MEDICAL OFFICER↗

The full record holds 74 transactions and goes back to Dec 30, 22.

Its sector and its market

Spruce Biosciences Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Spruce Biosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Spruce Biosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
340 documents on file, from Sep 4, 2020 to Aug 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.